The next health policy debate begins now, and the future direction of health reform seems more uncertain than ever. Now is the time to take advantage of the detailed, forward-looking reporting that only Inside Health Policy delivers.

Sign up for 30 days of no-obligation access for all the essential news during this critical time.


Top Story

At Least Two AGs Plan To Sue Administration Over Association Health Plan Rule

The attorneys general from New York and Massachusetts are already planning to sue the Trump administration over the association health plan rule finalized Tuesday (June 19), saying the rule promotes fraud and abuse and steps on congressional turf.

Stakeholders At Odds As Trump Administration Finalizes Association Health Plan Rule

Latest News

CMS on Wednesday (June 20) asked stakeholders for feedback on how the physician self-referral law, or Stark law, exemptions are working and what changes are needed to reduce barriers to care coordination for alternative pay models.

The House of Representatives voted Wednesday (June 20) to allow Medicaid to pay for some substance abuse treatment in large inpatient facilities and to ease privacy restrictions for medical records containing information about substance abuse.

The House on Tuesday (June 19) voted 342-13 to pass a bill that would direct FDA to work with drug manufacturers to establish programs to return or dispose of unused Schedule II and III substances.

Hospitals, doctors and health systems groups are asking CMS to give providers more time to decide whether to participate in the new Bundled Payments for Care Improvement Advanced model, given that providers only received important data and information on the model in the beginning of June.

Maine Gov. Paul LePage (R), steadfast in his refusal to implement the state’s voter-approved Medicaid expansion, is asking the state’s supreme court for a stay of a lower court ruling that he must submit paperwork to CMS to start the expansion--even as Maine's lawmakers reconvened Tuesday (June 19) and took up legislation to fund the state’s share of expanding the program.

After initially being blocked by House Republican committee leaders, a proposal to expand the authority of non-physicians to prescribe buprenorphine ended up in the umbrella legislation on opioids that the House will vote on this week because the Drug Enforcement Agency dropped its objections to the proposal, according to a congressional aide.

Facing pressure from appropriators, lawmakers and stakeholders, FDA signaled Tuesday (June 19) it is rethinking its controversial move to require pure maple syrup and pure honey be labeled as having “added sugar.”

The House of Representatives will continue voting this week on a trove of bills aimed at alleviating the opioid crisis, including controversial measures on Medicaid payments for inpatient treatment, medical privacy for people with substance use disorders and expanded prescribing authority for buprenorphine.

Lawyers representing outsourcing compounders are signaling they may sue FDA should it finalize guidance outlining its plans to evaluate whether there is a clinical need to compound a drug using bulk active pharmaceutical ingredients.